Cargando…
Adherence to recommendations for secondary prevention medications after myocardial infarction in Estonia: comparison of real-world data from 2004 to 2005 and 2017 to 2018
BACKGROUND: Relatively high rates of adherence to myocardial infarction (MI) secondary prevention medications have been reported, but register-based, objective real-world data is scarce. We aimed to analyse adherence to guideline-recommended medications for secondary prevention of MI in 2017 to 2018...
Autores principales: | Lõiveke, Piret, Marandi, Toomas, Ainla, Tiia, Fischer, Krista, Eha, Jaan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527758/ https://www.ncbi.nlm.nih.gov/pubmed/34670499 http://dx.doi.org/10.1186/s12872-021-02321-x |
Ejemplares similares
-
Improved treatment and prognosis after acute myocardial infarction in Estonia: cross-sectional study from a high risk country
por: Saar, Aet, et al.
Publicado: (2015) -
Lifeday coverage of oral anticoagulants and one-year relative survival in patients with atrial fibrillation: a population-based study in Estonia
por: Pauklin, Priit, et al.
Publicado: (2023) -
Use of evidence-based pharmacotherapy after myocardial infarction in Estonia
por: Marandi, Toomas, et al.
Publicado: (2010) -
Changes in treatment and mortality of acute myocardial infarction in Estonian tertiary and secondary care hospitals in 2001 and 2007
por: Blöndal, Mai, et al.
Publicado: (2012) -
Sex-specific outcomes of diabetic patients with acute myocardial infarction who have undergone percutaneous coronary intervention: a register linkage study
por: Blöndal, Mai, et al.
Publicado: (2012)